BVF as of Sept. 30, 2014
Portfolio Holdings for BVF
BVF holds 32 positions in its portfolio as reported in the September 2014 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Ironwood Pharmaceuticals (IRWD) | 15.1 | $73M | 5.6M | 12.96 | |
Receptos | 14.8 | $71M | 1.1M | 62.11 | |
Ligand Pharmaceuticals In (LGND) | 10.8 | $52M | 1.1M | 46.99 | |
Array BioPharma | 10.3 | $50M | 14M | 3.57 | |
Chemocentryx | 8.0 | $39M | 8.6M | 4.50 | |
Oncomed Pharmaceuticals | 5.1 | $24M | 1.3M | 18.93 | |
Oncothyreon | 3.9 | $19M | 9.9M | 1.92 | |
Five Prime Therapeutics | 3.6 | $17M | 1.5M | 11.73 | |
Targacept | 3.5 | $17M | 6.7M | 2.53 | |
Loxo Oncology | 3.2 | $16M | 1.2M | 13.13 | |
Concert Pharmaceuticals I equity | 3.2 | $15M | 1.2M | 12.61 | |
Array Biopharma Inc note 3.000% 6/0 | 3.0 | $14M | 16M | 0.90 | |
Exelixis Inc cnv | 2.1 | $10M | 17M | 0.58 | |
Qlt | 2.0 | $9.5M | 2.1M | 4.52 | |
Proqr Thrapeutics N V shs euro (PRQR) | 2.0 | $9.4M | 549k | 17.19 | |
Trevena | 1.5 | $7.2M | 1.1M | 6.42 | |
Ardelyx (ARDX) | 1.3 | $6.4M | 454k | 14.21 | |
Cytokinetics (CYTK) | 1.1 | $5.4M | 1.5M | 3.52 | |
Vitae Pharmaceuticals | 1.1 | $5.1M | 666k | 7.63 | |
ArQule | 1.0 | $4.8M | 4.3M | 1.12 | |
Regado Biosciences | 0.6 | $2.9M | 2.6M | 1.13 | |
Biolinerx Ltd-spons | 0.5 | $2.3M | 1.5M | 1.54 | |
OncoGenex Pharmaceuticals | 0.4 | $1.8M | 662k | 2.67 | |
Kalobios Pharmaceuticals | 0.4 | $1.8M | 1.2M | 1.55 | |
Sophiris Bio | 0.4 | $1.8M | 600k | 2.93 | |
Regulus Therapeutics | 0.3 | $1.3M | 185k | 6.83 | |
Achaogen | 0.2 | $1.2M | 137k | 8.96 | |
Biota Pharmaceuticals | 0.2 | $1.1M | 436k | 2.47 | |
Anthera Pharmaceutcls | 0.2 | $1.1M | 560k | 1.92 | |
Uniqure Nv (QURE) | 0.2 | $981k | 107k | 9.21 | |
Palatin Technologies | 0.1 | $698k | 751k | 0.93 | |
Transcept Pharmaceuticals | 0.1 | $305k | 150k | 2.03 |